CAMZYOS (mavacamten) is a prescription medication developed by Bristol Myers Squibb for the treatment of symptomatic obstructive hypertrophic cardiomyopathy (HCM) in adults. The platform serves as a Healthcare Professional finder tool, enabling providers to locate REMS-certified clinicians with experience prescribing the drug, which carries a boxed warning for heart failure risk.

LLM mention score The LLM mention score is the total number of mentions of this brand in different LLM chatbots, normalized to the scale from 0 to 100. You can get actual, non-normalized numbers via the LLM Mention API from DataForSEO.

Normalized 0–100 · last 8 weeks

DataForSEO API

Get LLM mention data of any company via DataForSEO API

Get access to the structured data on keyword, brand, and website mentions in LLMs, including metrics like AI search volume, impressions, and mentions count. 

How to get LLM mention data →
// Fetch CAMZYOS mentions
POST v3/ai_optimization/llm_mentions/search_mentions/live
[
    {
        "target": [
            {
                "domain": "camzyosfinder.com",
                "search_filter": "include",
                "search_scope": ["sources"]
            }
        ],
        "order_by": ["ai_search_volume,desc"]
    }
]